Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$322.86 USD

322.86
739,181

+0.15 (0.05%)

Updated May 17, 2024 04:00 PM ET

After-Market: $322.73 -0.13 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 13% (32 out of 249)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Should Value Investors Buy HCA Healthcare (HCA) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

HCA Healthcare (HCA) Dips More Than Broader Market: What You Should Know

by Zacks Equity Research

HCA Healthcare (HCA) reachead $313.20 at the closing of the latest trading day, reflecting a -0.68% change compared to its last close.

Is It Worth Investing in HCA (HCA) Based on Wall Street's Bullish Views?

by Zacks Equity Research

Based on the average brokerage recommendation (ABR), HCA (HCA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

HCA Healthcare (HCA) Drives Efficiency With New Outpatient Model

by Zacks Equity Research

HCA Healthcare's (HCA) Sarah Cannon Cancer Institute adopts a new outpatient model for CAR T-cell therapy patients.

Here's Why HCA Healthcare (HCA) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Universal Health Services, Inc. (UHS) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

HCA Healthcare, Inc. (HCA) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to HCA (HCA). This makes it worthwhile to examine what the stock has in store.

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

by Zacks Equity Research

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Here's How Much You'd Have If You Invested $1000 in HCA Healthcare a Decade Ago

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Zacks Investment Ideas feature highlights: HCA Healthcare, DaVita and General Motors

by Zacks Equity Research

HCA Healthcare, DaVita and General Motors have been highlighted in this Investment Ideas article.

Ethan Feller headshot

Markets Appear Vulnerable: Hideout in these 3 Top Ranked Defensive Stocks

by Ethan Feller

There are a number of bearish catalysts brewing... is it time to rotate into these defensive names?

John Blank headshot

Nvidia Reports on the A.I. Boom: Global Week Ahead

by John Blank

After Nvidia's stock more than tripled in 2023, the chipmaker at the center of the excitement over A.I. has seen its shares soar another roughly +50% so far this year.

Why HCA Healthcare (HCA) is a Top Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Nalak Das headshot

5 Must-Buy Growth Stocks for Sparkling Returns in Near Future

by Nalak Das

We have narrowed our search to five growth stocks that have solid upside left for 2024. These are: AMZN, RCL, PGR, HCA, APP.

Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Elevance Health (ELV) and HCA Healthcare (HCA) have performed compared to their sector so far this year.

Supriyo Bose headshot

5 High ROE Stocks to Bet on as Markets Sway Whimsically

by Supriyo Bose

Arch Capital (ACGL), Suzano (SUZ), Carlisle (CSL), HCA Healthcare (HCA) and America Movil (AMX) are some of the stocks with high ROE to profit from as markets swing wildly.

Zacks Investment Ideas feature highlights: HCA Healthcare, The Progressive and Dell Technologies

by Zacks Equity Research

HCA Healthcare, The Progressive and Dell Technologies are part of the Zacks Investment Ideas article.

Ethan Feller headshot

Higher for Longer: 3 Stocks to Benefit from Falling Rate Cut Expectations

by Ethan Feller

With a robust labor market and higher than expected inflation, we can expect rates to stay high for at least a few more months

Are Investors Undervaluing HCA Healthcare (HCA) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Ethan Feller headshot

Momentum Monday: Inflation Data, Earnings, and Semiconductors

by Ethan Feller

Want to start the week ahead of the pack? Check out Momentum Mondays

Nalak Das headshot

5 Must-Buy S&P 500 Stocks as Index Crosses Key Milestone

by Nalak Das

We have narrowed our search to five U.S. corporate behemoths in the S&P stable. These are: AMZN, META, NFLX, PGR, HCA.

Catalent (CTLT) Q2 Earnings Lag Estimates, Gross Margin Down

by Zacks Equity Research

Catalent (CTLT) reports lower revenues in Biologics segments in its second-quarter fiscal 2024, resulting in overall soft performance.

Haemonetics (HAE) Q3 Earnings Top Estimates, 2024 View Raised

by Zacks Equity Research

Haemonetics' (HAE) proprietary technology, Persona, continues to gain momentum in the third quarter.

Why HCA Healthcare (HCA) is a Top Stock for the Long-Term

by Zacks Equity Research

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.